HP
NGVT icon

Harvey Partners’s Ingevity NGVT Stock Holding History

Harvey Partners’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.8M Sell
734,307
-9,193
-1% -$662K 3.76% 4
2026
Q1 		$53M Buy
743,500
+114,070
+18% +$7.8M 4.21% 4
2025
Q4 		$37.2M Buy
629,430
+28,430
+5% +$1.54M 3.3% 11
2025
Q3 		$33.2M Buy
601,000
+28,953
+5% +$1.51M 2.95% 12
2025
Q2 		$24.6M Buy
572,047
+213,547
+60% +$8.24M 2.42% 20
2025
Q1 		$14.2M Buy
358,500
+34,500
+11% +$1.53M 1.66% 25
2024
Q4 		$13.2M Buy
324,000
+122,000
+60% +$5.08M 1.47% 30
2024
Q3 		$7.88M Buy
+202,000
New +$8.05M 0.9% 38

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Harvey Partners's NGVT Position: Q2 2026 in Review

Harvey Partners reduced its Ingevity (NGVT) stake by 1.2% in Q2 2026, selling an estimated $662K and leaving 734,307 shares worth $54.8M. The position accounts for 3.76% of the portfolio, ranked #4.

Harvey Partners first reported a position in NGVT in Q3 2024 and has held it in 8 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Harvey Partners held 734,307 shares of Ingevity worth $54.8M as of Q2 2026.
  • Harvey Partners sold 9,193 Ingevity shares in Q2 2026, an estimated $662K.
  • Ingevity made up 3.76% of Harvey Partners's portfolio in Q2 2026, its #4 holding.
  • Harvey Partners first reported a position in Ingevity in Q3 2024 and has held it in 8 quarters since.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Harvey Partners's 13F filing for Q2 2026, filed 14 Aug 2026.